ArticleNPJ vaccines2026

A poorly reactogenic lipid nanoparticle-mRNA vaccine unveils an innate immune pathway for adverse reactions.

Tomohiro Takano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.